Literature DB >> 3264509

A comparative study of the formation of chemically reactive drug metabolites by human liver microsomes.

N R Kitteringham1, C Lambert, J L Maggs, J Colbert, B K Park.   

Abstract

1. The metabolism of amodiaquine (A), ethinyloestradiol (E), mianserin (M), phenytoin (Ph), sulphanilamide (S) and paracetamol (Pa) to both stable and chemically reactive, i.e. irreversibly protein bound, metabolites was investigated using microsomes prepared from histologically normal human liver obtained from eight kidney donors. 2. All drugs, except amodiaquine, were metabolized by NADPH-dependent microsomal enzymes to chemically reactive metabolites. The degree of NADPH-dependent binding varied between drugs (E, 11.5 +/- 5.8% incubated drug; M, 3.0 +/- 1.9%; Ph, 0.10 +/- 0.09%; S, 0.57 +/- 0.38%; Pa, 1.2 +/- 1.2%; mean of eight livers +/- s.d.). 3. Inclusion of glutathione (1 mM) or ascorbic acid (1 mM) in the incubation reduced the NADPH-dependent binding for all substrates, indicating the involvement of electrophilic oxidation products. 4. Binding of M and Pa correlated with each other (Spearman's r = 0.86) and with total cytochrome P-450 content (r = 0.76 and 0.78 respectively). E binding also correlated with the binding of M (r = 0.79) and Pa (r = 0.81) but not with cytochrome P-450. Binding of Ph and S did not correlate with any of the other measured metabolic parameters.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264509      PMCID: PMC1386494          DOI: 10.1111/j.1365-2125.1988.tb03358.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  32 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Progress in hepatology. Metabolic activation of drugs to toxic substances.

Authors:  J R Mitchell; D J Jollows
Journal:  Gastroenterology       Date:  1975-02       Impact factor: 22.682

3.  Positive skin reaction induced by 4,4'-azoxybenzenedisulfonamide in relationship to the sulfanilamide allergy.

Authors:  I Yamamoto; R Eyanagi
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

4.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

5.  Metabolic disposition and irreversible binding of phencyclidine in rats.

Authors:  F C Law
Journal:  Toxicol Appl Pharmacol       Date:  1981-02       Impact factor: 4.219

6.  An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  W F Greenlee; A Poland
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

7.  Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung.

Authors:  M R Boyd
Journal:  Nature       Date:  1977-10-20       Impact factor: 49.962

8.  Penicillin allergy and the heterogenous immune responses of man to benzylpenicillin.

Authors:  B B Levine; A P Redmond; M J Fellner; H E Voss; V Levytska
Journal:  J Clin Invest       Date:  1966-12       Impact factor: 14.808

9.  The metabolism of mianserin in women, rabbits, and rats: identification of the major urinary metabolites.

Authors:  G D de Jongh; H M van den Wildenberg; H Nieuwenhuyse; F van der Veen
Journal:  Drug Metab Dispos       Date:  1981 Jan-Feb       Impact factor: 3.922

10.  Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.

Authors:  A R Boobis; M J Brodie; G C Kahn; D R Fletcher; J H Saunders; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

View more
  9 in total

Review 1.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

2.  Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes.

Authors:  A P Li; N R Hartman; C Lu; J M Collins; J M Strong
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

3.  Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.

Authors:  L M Forrester; C J Henderson; M J Glancey; D J Back; B K Park; S E Ball; N R Kitteringham; A W McLaren; J S Miles; P Skett
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

4.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

5.  The immunological basis of adverse drug reactions. A report on a symposium held in Liverpool on 6th April 1988.

Authors:  B K Park; J W Coleman
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

6.  Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.

Authors:  R J Riley; P Roberts; M D Coleman; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

7.  Metabolism of ciamexon by human liver microsomes: an investigation into the formation of stable, chemically reactive and cytotoxic metabolites.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

8.  A stereochemical investigation of the cytotoxicity of mianserin metabolites in vitro.

Authors:  R J Riley; C Lambert; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

9.  An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.

Authors:  R J Riley; J L Maggs; C Lambert; N R Kitteringham; B K Park
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.